Invivyd is focused on delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2, for immunocompromised individuals.
Base: $120,000 - $160,000; Bonus/Equity: Eligible for annual short-term and long-term incentives; Benefits: Not specified
Must-have
Nice-to-have
Not specified